Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Verzenio
Verzenio
FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands
FDA widens Lilly's Verzenio breast cancer reach, removes test and menopausal status demands
Fierce Pharma
Eli Lilly
Verzenio
breast cancer
Flag link:
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Flag link:
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
Fierce Pharma
Eli Lilly
earnings
Trulicity
Taltz
Verzenio
Emgality
Flag link:
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Eli Lilly's Verzenio snags first-in-class FDA approval for early breast cancer. But limited label poses a challenge
Fierce Pharma
Eli Lilly
Verzenio
FDA
early breast cancer
breast cancer
Flag link:
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Fierce Pharma
Eli Lilly
pharma marketing
Olympics
Trulicity
Emgality
Verzenio
Flag link:
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Look for Eli Lilly's Verzenio to hit $4.6B, thanks to early breast cancer win: analyst
Fierce Pharma
Eli Lilly
Verzenio
breast cancer
early breast cancer
Flag link:
Ibrance trial failure dashes Pfizer’s growth hopes for the drug
Ibrance trial failure dashes Pfizer’s growth hopes for the drug
Pharmaforum
Pfizer
Ibrance
breast cancer
Eli Lily
Verzenio
Flag link:
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
Fierce Pharma
Ibrance
Pfizer
Eli Lilly
Verzenio
breast cancer
ESMO
Flag link:
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
Eli Lilly Shares Surge After Successful 'Verzenio' Breast Cancer Drug Trial
TheStreet.com
Eli Lilly
Verzenio
breast cancer
clinical trials
Flag link:
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
RAPS.org
breast cancer
FDA
Ibrance
Kisqali
Verzenio
Pfizer
Novartis
Eli Lilly
Flag link:
Lilly cancer push boosted by survival benefit to key drug
Lilly cancer push boosted by survival benefit to key drug
Biopharma Dive
Eli Lilly
Verzenio
metastatic breast cancer
clinical trials
Flag link:
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Eli Lilly
NICE
Verzenio
breast cancer
Flag link:
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
Flag link:
Lilly’s breast cancer drug Verzenio approved in EU
Lilly’s breast cancer drug Verzenio approved in EU
Pharmaforum
Eli Lilly
Verzenio
Euorpe
breast cancer
Flag link:
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Large and Small: Here’s What’s Moving Eli Lilly and Zosano
Yahoo/Market Exclusive
Eli Lilly
Zosano
Verzenio
advanced breast cancer
M207
migraine
Flag link:
AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio
AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio
Yahoo/Zacks.com
AstraZeneca
Faslodex
FDA
breast cancer
Verzenio
Eli Lilly
Flag link:
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Verzenio
Ibrance
Kisqali
drug launches
breast cancer. Eli Lilly
Pfizer
Novartis
Flag link:
Lilly's lung cancer drug fails main goal of key study
Lilly's lung cancer drug fails main goal of key study
Yahoo/Reuters
Eli Lilly
lung cancer
clinical trials
Verzenio
non-small cell lung cancer
Flag link:
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval
Lilly steps up to rival Pfizer, Novartis with Verzenio breast cancer approval
Fierce Pharma
Eli Lilly
Pfizer
Novartis
Verzenio
breast cancer
Ibrance
Kisqali
Flag link: